Morgan Stanley Covetrus, Inc. Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$20.69 - $20.91 $10.2 Million - $10.3 Million	493,644 Added 54.17%	1,404,876 $29.3 Million
Q2 2022 Oct 27, 2022	SELL	$13.8 - $20.82 $9.98 Million - $15.1 Million	-722,886 Reduced 44.24%	911,232 $18.9 Million
Q2 2022 Aug 15, 2022	SELL	$13.8 - $20.82 $9.98 Million - $15.1 Million	-722,886 Reduced 44.24%	911,232 $18.9 Million
Q1 2022 Oct 27, 2022	BUY	$15.96 - $18.87 $11.5 Million - $13.6 Million	722,886 Added 79.33%	1,634,118 $27.4 Million
Q1 2022 May 13, 2022	SELL	$15.96 - $18.87 $37.6 Million - $44.5 Million	-2,357,842 Reduced 59.06%	1,634,118 $27.4 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $20.37 $80.7 Million - $97.9 Million	-4,806,989 Reduced 54.63%	3,991,960 $79.7 Million
Q3 2021 Nov 15, 2021	BUY	$18.14 - $27.03 $160 Million - $238 Million	8,798,949 New	8,798,949 $160 Million

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.